Javascript Menu by Deluxe-Menu.com

Advanced Search
  Home Breaking News Newsletters Books & Reports Events Jobs Advisory Board Interviews e-Alert Contact Us
Diagnostic Imaging & Intelligence   •   G2 Compliance   •   Laboratory Industry   •   National Intelligence   •   Diagnostic Testing & Technology  
     
 
Diagnostic Testing & Technology Report

Lung Cancer-Focused Allegro Diagnostics Raises $4 Million
April 2008

Allegro Diagnostics (Boston) has completed a $4 million Series A financing round led by Kodiak Venture Partners and joined by Catalyst Health Ventures and Boston University. Founded in 2006, Allegro is a molecular diagnostics company focused on developing and commercializing products based on gene expression technology developed by Jerome Brody, M.D., and Avrum Spira, M.D., at the Boston University School of Medicine. Brody was recently appointed chief scientific officer of the company.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

   

 

Archives

 
     
  Home Privacy Awards & Scholarships Advisory Board Contact Us Advertising Blogs & Online Resources List Rentals

Copyright © 1999-2008 Washington G-2 Reports. No portion of the material presented on this site may be used without express written permission from authorized personnel at Washington G-2 Reports. Washington G-2 Reports is an operating unit of IOMA, the Institute of Management & Administration, Inc.